Clinical Trials for Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)

Find clinical trials for lymphoma patients with complete response (cr) or partial response (pr) after standard treatment had a positive minimal residual lesion (mrd). Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

RGL-305+ Lymphoma + Exploratory Clinical Study

NCT ID: NCT07006012

This clinical trial is exploring the use of a new treatment called RGL-305 for patients with lymphoma who have shown some response to previous standard treatments. Specifically, it is for patients ...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, Shanghai, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions